LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,103,563 | -55.7% | 105,755 | -54.5% | 0.01% | -44.4% |
| Q2 2023 | $16,039,534 | +124.6% | 232,356 | +56.9% | 0.01% | +125.0% |
| Q1 2023 | $7,140,321 | -4.6% | 148,078 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $7,486,803 | -14.2% | 149,976 | -29.9% | 0.00% | -20.0% |
| Q3 2022 | $8,726,000 | -25.1% | 213,876 | +1.0% | 0.01% | -28.6% |
| Q2 2022 | $11,652,000 | +31.4% | 211,842 | -13.2% | 0.01% | +75.0% |
| Q1 2022 | $8,870,000 | -9.3% | 244,085 | +16.3% | 0.00% | 0.0% |
| Q4 2021 | $9,780,000 | +84.3% | 209,827 | +99.9% | 0.00% | +33.3% |
| Q3 2021 | $5,307,000 | +1590.1% | 104,955 | +1268.4% | 0.00% | – |
| Q2 2021 | $314,000 | +107.9% | 7,670 | +47.7% | 0.00% | – |
| Q1 2021 | $151,000 | +2.7% | 5,193 | 0.0% | 0.00% | – |
| Q4 2020 | $147,000 | -8.1% | 5,193 | -0.1% | 0.00% | – |
| Q3 2020 | $160,000 | -31.0% | 5,197 | -4.5% | 0.00% | – |
| Q2 2020 | $232,000 | – | 5,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |